Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs

American Journal of Ophthalmology

Volumn 138, Issue 5, 2004, Pages 829-839

  Tameesh, Mohamed K ^a   Lakhanpal, Rohit R ^a   Fujii, Gildo Y ^a   Javaheri, Michael ^a   Shelley, Terry H ^b   D'Anna, Sam ^b   Barnes, Aaron C ^a   Margalit, Eyal ^b   Farah, Michel ^c   De Juan Jr , Eugene ^a   Humayun, Mark S ^a  

^a DOHENY EYE INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; ROSE BENGAL; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANNULATION; CATHETERIZATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DIODE LASER; DOG; DRUG EFFICACY; DRUG SAFETY; ENUCLEATION; EYE BLOOD FLOW; EYE FUNDUS; FLOW RATE; FLUORESCENCE ANGIOGRAPHY; HISTOLOGY; LASER COAGULATION; MEDICAL INSTRUMENTATION; NONHUMAN; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA VEIN OCCLUSION; SURGICAL TECHNIQUE; THROMBUS; VEIN DILATATION;

ANIMALS; CATHETERIZATION, PERIPHERAL; DISEASE MODELS, ANIMAL; DOGS; FEASIBILITY STUDIES; FIBRINOLYTIC AGENTS; FLUORESCEIN ANGIOGRAPHY; INFUSIONS, INTRAVENOUS; RETINAL VEIN; RETINAL VEIN OCCLUSION; SAFETY; SWINE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 7544239918     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.06.083     Document Type: Article

References (30)

1. R. Klein, B.E. Klein, S.E. Moss, S.M. Meuer The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study Trans Am Ophthalmol Soc 98 2000 133 141
2. S.S. Hayreh, P. Rojas, P. Podhajsky, P. Montague, R.F. Woolson Ocular neovascularization with retinal vascular occlusion-III Incidence of ocular neovascularization with retinal vein occlusion Ophthalmology 90 1983 488 506
3. The Central Vein Occlusion Study Group A randomized clinical trial of early photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N report Ophthalmology 102 1995 1434 1444
4. C.M. Greven, A.B. Wall Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance Am J Ophthalmol 124 1997 687 689
5. The Central Vein Occlusion Study Group Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report Ophthalmology 102 1995 1425 1433
6. I.L. McAllister, J.P. Douglas, I.J. Constable, D.Y. Yu Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors Am J Ophthalmol 126 1998 219 229
7. I.L. McAllister, I.J. Constable Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion Arch Ophthalmol 113 1995 456 462
8. S. Fekrat, E. de Juan Jr Chorioretinal venous anastomosis for central retinal vein occlusion: transvitreal venipuncture Ophthalmic Surg Lasers 30 1999 52 55
9. W.R. Green, C.C. Chan, G.M. Hutchins, J.M. Terry Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases Trans Am Ophthalmol Soc 79 1981 371 422
10. E.M. Kohner, J.E. Pettit, A.M. Hamilton, C.J. Bulpitt, C.T. Dollery Streptokinase in central retinal vein occlusion: a controlled clinical trial BMJ 1 1976 550 553
11. L.O. Hattenbach [Systemic lysis therapy in retinal vascular occlusions] Ophthalmologe 95 1998 568 575
12. L.O. Hattenbach, G. Wellermann, G.W. Steinkamp, I. Scharrer, F.H. Koch, C. Ohrloff Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion Ophthalmologica 213 1999 360 366
13. M.J. Elman Thrombolytic therapy for central retinal vein occlusion: results of a pilot study Trans Am Ophthalmol Soc 94 1996 471 504
14. A.J. Royster, S.K. Nanda, D.L. Hatchell Photochemical initiation of thrombosis Fluorescein angiographic, histologic, and ultrastructural alterations in the choroid, retinal pigment epithelium, and retina Arch Ophthalmol 106 1988 1608 1614
15. B.E. Allf, E. de Juan Jr In vivo cannulation of retinal vessels Graefes Arch Clin Exp Ophthalmol 225 1987 221 225
16. J.G. Cunha-Vaz, J.N. Murta, R.D. Proenca Micropuncture of retinal vessels Dev Ophthalmol 18 1989 90 94
17. M.R. Glucksberg, R. Dunn, C.P. Giebs In vivo micropuncture of retinal vessels Graefes Arch Clin Exp Ophthalmol 231 1993 405 407
18. W.M. Tang, D.P. Han A study of surgical approaches to retinal vascular occlusions Arch Ophthalmol 118 2000 138 143
19. J.N. Weiss Retinal surgery for treatment of central retinal vein occlusion Ophthalmic Surg Lasers 31 2000 162 165
20. S.Z. Goldhaber Thrombolytic therapy Adv Intern Med 44 1999 311 325
21. M. Heinz, W. Theiss [Thrombolytic therapy of venous thromboses] Internist (Berl) 37 1996 567 573
22. D.C. Gulba, C. Bode, M.S. Runge, K. Huber Thrombolytic agents-an overview Ann Hematol 73 Suppl 1 1996 S9 27
23. K. Kandarpa Catheter-directed thrombolysis of peripheral arterial occlusions and deep vein thrombosis Thromb Haemost 82 1999 987 996
24. A.J. Comerota, M.L. Katz, J.V. White Thrombolytic therapy for acute deep venous thrombosis: how much is enough? Cardiovasc Surg 4 1996 101 104
25. M. Oncel, G.A. Peyman, B. Khoobehi Tissue plasminogen activator in the treatment of experimental retinal vein occlusion Retina 9 1989 1 7
26. I.L. McAllister, D.Y. Yu, S. Vijayasekaran, C. Barry, I. Constable Induced chorioretinal venous anastomosis in experimental retinal branch vein occlusion Br J Ophthalmol 76 1992 615 620
27. E.M. Kohner, C.T. Dollery, M. Shakib Experimental retinal vein occlusion Am J Ophthalmol 69 1970 779 825
28. S.S. Hayreh, W.A. van Heuven, M.S. Hayreh Experimental retinal vascular occlusion I. Pathogenesis of central retinal vein occlusion Arch Ophthalmol 96 1978 311 323
29. S.S. Hayreh So-called central retinal vein occlusion I Pathogenesis, terminology, clinical features. Ophthalmologica 172 1976 1 13
30. J.N. Weiss, L.A. Bynoe Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion Ophthalmology 108 2001 2249 2257